Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
These data suggest that breast cancer cell line-derived IGF-I is similar to liver-synthesized, serum-derived IGF-I.
|
3731113 |
1986 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
We describe studies on human breast cancer in which it is shown that specific growth factors (IGF-I, TGF alpha, PDGF) are secreted by human breast cancer cells and likely to be involved in tumor growth and progression.
|
3312244 |
1987 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Estrogen receptor (ER)-negative MDA-231 human breast cancer cells have been shown to secrete high concentrations of several growth factors including transforming growth factor-alpha and insulin-like growth factor I, which could have important autocrine or paracrine growth regulatory functions and, additionally, could explain the rapid autonomous growth of these cells.
|
3167228 |
1988 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells.
|
3041262 |
1988 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In contrast to breast cancer cell lines, RNA extracted from breast tissues has easily detectable IGF-I mRNA.
|
2747657 |
1989 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
This study demonstrates that some breast cancer cells express the IGF-I binding protein, BP-25.
|
2463838 |
1989 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We conclude that type I and type II IGF receptors are ubiquitously expressed in breast cancer, and our experiments with MCF-7 cells suggest the mitogenic effects of both IGF-I and IGF-II are mediated via the type I IGF receptor.
|
2152773 |
1990 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
We have identified and characterized a novel human insulin-like growth factor I (IGF-I) precursor from the transplantable T61 human breast cancer xenograft and from normal liver.
|
2082190 |
1990 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
IGF-I and estradiol had similar synergistic effects on other estrogen-responsive breast cancer cell lines, but IGF-I alone increased the proliferation of the MDA MB-231 cell line which is not responsive to estrogens.
|
2174437 |
1990 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Insulin-like growth factor-I (IGF-I) receptors are present in breast cancer cells and may play a role in breast cancer cell growth.
|
1649393 |
1991 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
These data imply that stromal cells associated with breast epithelium may switch expression from IGF-I to IGF-II during breast cancer evolution.
|
1421422 |
1992 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence.
|
1421423 |
1992 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Nevertheless, IGF-I mRNA can be detected in breast cancer tissue samples, and in situ hybridization studies have shown that the message originates from the stromal cells adjacent to normal lobules.
|
1421420 |
1992 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
The T47D human breast carcinoma cell line has been shown to synthesize insulin-like growth factor-I (IGF-I) binding proteins (IGFBPs) and IGF-I receptors, and to exhibit a mitogenic response to exogenous IGF-I.
|
7521344 |
1993 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in a breast carcinoma cell line.
|
8125161 |
1994 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We have analyzed the stromal mRNA expression of IGF-I and IGF-II in matched sets of fibroblast cell lines derived from three locations in the affected breast of eight patients with breast cancer: (a) the breast tumor itself; (b) surrounding normal breast tissue; and (c) overlying breast skin.
|
7757999 |
1995 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.
|
8595162 |
1996 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Both the insulin and IGF-I receptors (IGF-IR) are overexpressed in breast cancer, and antibody blockade of the IGF-IR inhibits the growth of some breast cancer cell lines.
|
8665514 |
1996 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Four lines of evidence lead us to conclude that E2 induces BRCA1 primarily through an increase in DNA synthesis: (1) The kinetics and magnitude of induction are different from the directly E2 inducible gene, pS2; (2) Induction of BRCA1, but not pS2, is blocked by cycloheximide indicating that de novo protein synthesis is required; (3) Other hormonal and growth factor treatments that induce DNA synthesis have a similar effect, including IGF-1, EGF and DNA synthetic flares induced by tamoxifen and retinoic acid; (4) BRCA1 genomic fragments near the 5' end of the gene containing putative estrogen response elements fail to respond to E2 when transfected into breast cancer cell lines.
|
9010238 |
1997 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
|
9014838 |
1997 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
This case-control study was designed to investigate whether patients with breast cancer have altered levels of either IGF-1 or its intermediary modulatory proteins, the IGF binding proteins (BP).
|
9527274 |
1998 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Insulin-like growth factors I and II (IGF-I and IGF-II) are potent mitogens involved in growth regulation of breast epithelial cells and are implicated in the pathophysiology of breast cancer.
|
9735418 |
1998 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Expression of mRNA encoding for IGF-1, IGF-2, IGF-receptor 1 and 2, IGF binding proteins- 1 to -6, insulin receptor and insulin was determined in the NIH MCF-7 breast cancer cell line, in specimens from breast cancer tissues, and in 6 primary breast cancer cell cultures obtained from metastatic breast cancer, using rT-PCR technique.
|
9615787 |
1998 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
By linking IGFBP-3 to RARbeta, our experiments define the signal intersection between the retinoid and IGF systems in cell growth regulation and explain why loss of RARbeta might be critical in breast cancer carcinogenesis/progression.
|
10364250 |
1999 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Pharmacological agents which lower IGF-1 concentrations are under clinical trial for breast cancer prevention.
|
10099938 |
1999 |